Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a software update; it does not modify the study text, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-25T18:13:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a minor build/template update that does not modify study content.
    Difference
    0.1%
    Check dated 2026-07-04T13:23:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2 instead of v3.6.0, indicating a newer build of the site. This update records the release version displayed for the page.
    Difference
    0.1%
    Check dated 2026-06-27T07:36:47.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended with a note 'No longer looking for participants.' New help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the Intervention/Treatment label formatting was updated.
    Difference
    0.6%
    Check dated 2026-06-13T05:09:10.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small, non-substantive update to the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:15:45.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend/template update to the page without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-05-15T14:07:28.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.